Primary Job Title Chief Financial Officer Primary Organization 
Eloxx
Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
Greg Weaver joined PLI as CFO in November 2015. Greg is an experienced CFO and board director, having served in executive positions with biopharma companies in the US and Europe.
Most recently he served as CFO and board director with Oryzon Genomics in Boston and Barcelona, and previously has served as CFO with the following Nasdaq-listed
public biotech companies: Fibrocell, Celsion, Poniard, Sirna, Nastech, and ILEX. Greg currently serves on the boards of public biotech companies Egalet, and Atossa Genetics.
Greg has led the raise of over US$800 million in various financing transactions throughout his career, and has led companies through IPO, drug development, and revenue growth, while positioning a number of companies for successful acquisition. Greg began his career as a CPA with Arthur Andersen, with an MBA from Boston College and BS in accounting from Trinity University.
